Telogen Effluvium: A Review of the Literature

The document from May 27, 2020, reviewed Telogen Effluvium, a common cause of hair loss. This condition can be triggered by various factors and alters the hair cycle, leading to acute or chronic hair fall. Diagnostic tests include hair wash test, trichogram, phototrichogram, and scalp biopsy. Treatment involves identifying and removing causative factors and using drugs like corticosteroids, minoxidil, and a novel treatment called CNPDA. The incidence rate is higher in females, and in children, it's around 2.7%. The disorder can last less than six months (acute) or more than six months (chronic). The document concluded that while some treatment options were available, standard guidelines for therapy, frequency, and dosage of drugs needed to be established.